| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/23/2013 | CN102406718B Normal-temperature preparation method of ultramicro Bailong powde |
| 10/23/2013 | CN102406707B Normal-temperature preparation method of ultramicro Scutellaria baicalensis powder and special bidirectional airflow screening machine thereof |
| 10/23/2013 | CN102397534B Use of insulin in preparation of drug for promoting jaw bone tissue healing |
| 10/23/2013 | CN102362973B Medicinal composition for treating calciprivia in children and preparation method thereof |
| 10/23/2013 | CN102362908B Medicinal composition for treating kidney-yang deficiency and preparation method thereof |
| 10/23/2013 | CN102357071B Taxol-carried nano microbubble and preparation method thereof |
| 10/23/2013 | CN102247326B Oral chronopharmacologic drug delivery mini-pill preparation of propranolol and its salts |
| 10/23/2013 | CN102131496B Improvement of composition or improvement relative to composition |
| 10/23/2013 | CN102105140B Method for coating tablets |
| 10/23/2013 | CN102089132B Method of manufacturing cellular films directly |
| 10/23/2013 | CN102083414B Composition comprising antibiotic and corticosteroid |
| 10/23/2013 | CN102068473B Medicinal composition, preparation method, preparation and application thereof |
| 10/23/2013 | CN102014878B Formulations for enhanced bioavailability of orally administered polar agents |
| 10/23/2013 | CN102008492B Oral medicinal composition of glycyrrhizic acid or glycyrrhetate and preparation method thereof |
| 10/23/2013 | CN101998850B Process for recovering florfenicol from pharmaceutical compositions |
| 10/23/2013 | CN101965201B Intralymphatic chemotherapy drug carriers |
| 10/23/2013 | CN101919822B Tablet with improved combination properties and preparation method thereof |
| 10/23/2013 | CN101854921B Pharmaceutical formulations for oral administration of PPI |
| 10/23/2013 | CN101677943B Multi-dose concentrate esmolol with benzyl alcohol |
| 10/23/2013 | CN101583339B Compositions comprising macromolecular assemblies of lipid and surfactant |
| 10/23/2013 | CN101437493B DPP IV inhibitor formulations |
| 10/23/2013 | CN101106996B Use of oxycodone for treating visceral pain |
| 10/22/2013 | US8563693 Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III |
| 10/22/2013 | US8563518 Cyclosporin compositions |
| 10/22/2013 | US8563082 Method for producing a cross-linked substance, especially in the form of a microcapsule or layer |
| 10/22/2013 | US8563072 Suspension containing hydronium stabilized colloidal silicic acid nanoparticles, formulation obtained from the said diluted suspension, powder obtained from the said de-hydrated suspension, compositions obtained from the said powder, preparation and use |
| 10/22/2013 | US8563053 Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis |
| 10/22/2013 | US8563050 Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure |
| 10/22/2013 | US8563044 Microparticle dispersion liquid manufacturing method and microparticle dispersion liquid manufacturing apparatus |
| 10/22/2013 | US8563043 Innately multimodal nanoparticles |
| 10/22/2013 | US8563042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 10/22/2013 | US8563041 Therapeutic particles suitable for parenteral administration and methods of making and using same |
| 10/22/2013 | US8563040 Compositions and methods for forming and strengthening bone |
| 10/22/2013 | US8563039 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions |
| 10/22/2013 | US8563038 Formulations and methods for the controlled release of active drug substances |
| 10/22/2013 | US8563037 Compositions and methods for joining non-conjoined lumens |
| 10/22/2013 | US8563036 Pharmaceutical compositions comprising Brivaracetam |
| 10/22/2013 | US8563035 Oral tablet compositions of dexlansoprazole |
| 10/22/2013 | US8563033 Orally effective methylphenidate extended release powder and aqueous suspension product |
| 10/22/2013 | US8563032 Formulation and manufacturing process for calcium acetate capsules |
| 10/22/2013 | US8563031 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith |
| 10/22/2013 | US8563030 Singultus-stopping article and composition |
| 10/22/2013 | US8563028 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 10/22/2013 | US8563024 Biodegradable material components |
| 10/22/2013 | US8563016 Lamellar oil-in-glycol gel compositions and the process of preparation |
| 10/22/2013 | US8563014 Modafinil oral lyophilizate |
| 10/22/2013 | US8563013 Systems and methods for delivering a fluid drug |
| 10/22/2013 | US8563012 Compositions and methods for administering compartmentalized frozen particles |
| 10/22/2013 | US8563011 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 10/22/2013 | US8562981 Stable digestive enzyme compositions |
| 10/22/2013 | US8562980 Stable digestive enzyme compositions |
| 10/22/2013 | US8562979 Stable digestive enzyme compositions |
| 10/22/2013 | US8562978 Stable digestive enzyme compositions |
| 10/22/2013 | US8562966 End-modified poly(beta-amino esters) and uses thereof |
| 10/22/2013 | US8562953 Dendritic polymers and magnetic resonance imaging contrast agent employing the same |
| 10/22/2013 | US8562952 Methods for manipulating satiety |
| 10/22/2013 | US8562669 Methods of application of coatings composed of hydrophobic, high glass transition polymers with tunable drug release rates |
| 10/22/2013 | US8562591 Drug infusion system and method adapted to start during programming cycle |
| 10/22/2013 | US8562590 Systems and methods for sustained medical infusion and devices related thereto |
| 10/22/2013 | US8562589 Swallowable drug delivery device and method of delivery |
| 10/22/2013 | US8561282 Method of coupling container body and cover member |
| 10/22/2013 | CA2707100C Morpholino compound microemulsion |
| 10/22/2013 | CA2699271C Needle-less parenteral introduction device |
| 10/22/2013 | CA2660991C Compositions comprising calcium citrate malate and methods for making the same |
| 10/22/2013 | CA2621377C Antitumor agent |
| 10/22/2013 | CA2613977C Method for producing a powder containing xylitol crystal particles with another polyol |
| 10/22/2013 | CA2602776C Method for treating prostate diseases based on local delivery of active substances |
| 10/22/2013 | CA2588295C Method and composition for administering an nmda receptor antagonist to a subject |
| 10/22/2013 | CA2580890C Viscoelastic solution or gel formulation, and methods of treating a body site with the same |
| 10/22/2013 | CA2566837C Anti acne skincare composition and skincare article |
| 10/22/2013 | CA2566199C Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
| 10/22/2013 | CA2554052C Ternary non-lamellar lipid compositions of structure forming amphiphile, structure swelling amphiphile and dispersion stabilising amphiphile |
| 10/22/2013 | CA2455129C Improvements in the extraction of pharmaceutically active components from plant materials |
| 10/22/2013 | CA2429665C Method of making particles for use in a pharmaceutical composition |
| 10/22/2013 | CA2424001C Oral preparations with favorable disintegration characteristics |
| 10/17/2013 | WO2013155493A1 Methods of treating inflammatory and autoimmune diseases and disorders |
| 10/17/2013 | WO2013155487A1 Vehicles for controlled delivery of different pharmaceutical agents |
| 10/17/2013 | WO2013155430A1 Soft elastic capsules containing tablets and liquid or semisolid fills and methods for their manufacture |
| 10/17/2013 | WO2013155404A1 Methods and compositions for preparing a silk microsphere |
| 10/17/2013 | WO2013155374A2 Cholesterol efflux assay probe formulations, methods of making and using |
| 10/17/2013 | WO2013155134A1 Non-immunogenic delivery vehicle for beta-, gamma-, and delta- tocopherols and methods of using and making same |
| 10/17/2013 | WO2013155047A2 Compounds and methods for inhibiting cif virulence factor |
| 10/17/2013 | WO2013154981A1 Melt-extruded composition comprising a cellulose ether |
| 10/17/2013 | WO2013154980A1 Composition comprising an organic diluent and a cellulose ether |
| 10/17/2013 | WO2013154977A1 Novel sustained release dosage forms |
| 10/17/2013 | WO2013154667A1 Hollow drug-filled stent and method of forming hollow drug-filled stent |
| 10/17/2013 | WO2013154607A1 Esterified cellulose ethers having a specific substituent distribution |
| 10/17/2013 | WO2013154512A1 Pharmaceutical formulations comprising dexibuprofen |
| 10/17/2013 | WO2013154511A1 Film tablet formulations comprising dexibuprofen |
| 10/17/2013 | WO2013154390A1 Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same |
| 10/17/2013 | WO2013154359A1 Nano-emulsion composition and method for producing the same |
| 10/17/2013 | WO2013154347A1 Liquid formulation for oral administration comprising ambroxol, levodropropizine and buffering agent, and method for preparing the same |
| 10/17/2013 | WO2013154290A1 Ceria nanocomplex, pharmaceutical composition comprising said ceria nanocomplex, and method for preparing same |
| 10/17/2013 | WO2013154209A1 Antiprotozoan composition containing caspofungin or its salt and biguanide compound or its salt |
| 10/17/2013 | WO2013154192A1 Medicinal composition for treating infarction |
| 10/17/2013 | WO2013154045A1 Composition for injectable solution |
| 10/17/2013 | WO2013153559A1 Fulvestrant formulations |
| 10/17/2013 | WO2013153349A2 Pharmaceutical composition |
| 10/17/2013 | WO2013153221A1 Vesicular formulations for use in the treatment of pain or reduced mobility of a joint |
| 10/17/2013 | WO2013153210A1 Sustained-release formulation |